Fosaprepitant
Product Images NDC 81952-911

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 81952-911). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hepalink Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Fig 1 Carton)

FOSAPREPITANT 150 mg per vial carton label for injection, by Hepalink USA Inc. The label states the drug is a sterile lyophilized powder for intravenous use after reconstitution with 5 mL of 0.9% Sodium Chloride. It includes usage warnings, inactive ingredients list, manufacturer details, storage instructions, and a barcode. The country of origin is China.*

FDA Label Image

Chemical Structure (M01 Chemical Structure)

Chemical structure of the active ingredient in FOSAPREPITANT, showing the detailed molecular components including fluorine, trifluoromethyl groups, and phosphate moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.